Listing

Biotech company Guard Therapeutics has received conditional approval from Nasdaq Stockholm for continued listing of its shares on Nasdaq First North.

Tunatumia vidakuzi kwa uchambuzi ili kuboresha tovuti yetu. Soma sera ya faragha yetu kwa maelezo zaidi.